- Home
- DOUG vs KRRO Comparison
DOUG vs KRRO Comparison
Compare DOUG & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOUG
- KRRO
- Stock Information
- Founded
- DOUG 1911
- KRRO 2014
- Country
- DOUG United States
- KRRO United States
- Employees
- DOUG N/A
- KRRO N/A
- Industry
- DOUG Building operators
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- DOUG Real Estate
- KRRO Health Care
- Exchange
- DOUG Nasdaq
- KRRO Nasdaq
- Market Cap
- DOUG 161.5M
- KRRO 147.4M
- IPO Year
- DOUG N/A
- KRRO 2019
- Fundamental
- Price
- DOUG $2.89
- KRRO $33.18
- Analyst Decision
- DOUG
- KRRO Strong Buy
- Analyst Count
- DOUG 0
- KRRO 7
- Target Price
- DOUG N/A
- KRRO $96.71
- AVG Volume (30 Days)
- DOUG 471.0K
- KRRO 219.3K
- Earning Date
- DOUG 11-05-2025
- KRRO 08-12-2025
- Dividend Yield
- DOUG N/A
- KRRO N/A
- EPS Growth
- DOUG N/A
- KRRO N/A
- EPS
- DOUG N/A
- KRRO N/A
- Revenue
- DOUG $1,034,406,000.00
- KRRO $6,281,000.00
- Revenue This Year
- DOUG $17.61
- KRRO $97.27
- Revenue Next Year
- DOUG N/A
- KRRO N/A
- P/E Ratio
- DOUG N/A
- KRRO N/A
- Revenue Growth
- DOUG 8.69
- KRRO N/A
- 52 Week Low
- DOUG $1.35
- KRRO $10.29
- 52 Week High
- DOUG $3.20
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- DOUG 63.06
- KRRO 84.05
- Support Level
- DOUG $2.50
- KRRO $20.20
- Resistance Level
- DOUG $2.76
- KRRO $24.69
- Average True Range (ATR)
- DOUG 0.12
- KRRO 2.81
- MACD
- DOUG 0.03
- KRRO 1.03
- Stochastic Oscillator
- DOUG 89.11
- KRRO 90.38
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.